{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:16:56Z","timestamp":1773937016442,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.nucmedbio.2024.108905","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:48:45Z","timestamp":1710816525000},"page":"108905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin \u2013 A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE"],"prefix":"10.1016","volume":"132-133","author":[{"given":"Ida Vang","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha Shalina Rajani","family":"Bidesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Shalgunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Tranekj\u00e6r","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Str\u00f8mgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas T.","family":"Ingemann Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias M.","family":"Herth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108905_bb0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0010","doi-asserted-by":"crossref","DOI":"10.1124\/pr.117.015388","article-title":"International Union of Basic and Clinical Pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature","volume":"70","author":"G\u00fcnther","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2009.12.003","article-title":"Pituitary somatostatin receptor signaling","volume":"21","author":"Ben-Shlomo","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/926295","article-title":"Peptide receptor targeting in cancer: the somatostatin paradigm","volume":"2013","author":"Barbieri","year":"2013","journal-title":"Int J Pept"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0025","first-page":"154","article-title":"Somatostatinergic systems: an update on brain functions in normal and pathological aging","volume":"Lausanne). 3","author":"Martel","year":"2012","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s12276-021-00580-4","article-title":"The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders","volume":"53","author":"Song","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0035","first-page":"311","article-title":"Somatostatin receptor PET ligands - the next generation for clinical practice","volume":"8","author":"Pauwels","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.116.180430","article-title":"Head-to-head comparison of (64)cu-DOTATATE and (68)Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors","volume":"58","author":"Johnbeck","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0045","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/cr900325h","article-title":"Coordinating Radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease","volume":"110","author":"Wadas","year":"2010","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2967\/jnmt.122.263814","article-title":"(177)Lu-PSMA therapy","volume":"50","author":"Parent","year":"2022","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-2006-939842","article-title":"Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver","volume":"23","author":"Lewandowski","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0060","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.115.156539","article-title":"64Cu-DOTATATE PET for neuroendocrine tumors: a prospective head-to-head comparison with 111In-DTPA-octreotide in 112 patients","volume":"56","author":"Pfeifer","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26030544","article-title":"Evaluation of [64Cu]cu-NOTA-PEG7-H-Tz for Pretargeted imaging in LS174T xenografts\u2014comparison to [111In]in-DOTA-PEG11-BisPy-Tz","volume":"26","author":"Poulie","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0070","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.112.102764","article-title":"Unexpected sensitivity of sst2 antagonists to N-terminal Radiometal modifications","volume":"53","author":"Fani","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111980","article-title":"Modulating the blood&ndash;brain barrier: a comprehensive review","volume":"13","author":"Whelan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120942","article-title":"Reversible blood-brain barrier opening utilizing the membrane active peptide melittin in vitro and in vivo","volume":"275","author":"Linville","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0085","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.bbamem.2008.06.007","article-title":"Toroidal pores formed by antimicrobial peptides show significant disorder","volume":"1778","author":"Sengupta","year":"2008","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10540-006-9030-z","article-title":"Melittin: a membrane-active peptide with diverse functions","volume":"27","author":"Raghuraman","year":"2007","journal-title":"Biosci Rep"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1\u2013SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneumeth.2013.11.008","article-title":"Cannulation of the internal carotid artery in mice: a novel technique for intra-arterial delivery of therapeutics","volume":"222","author":"Santillan","year":"2014","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0105","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1021\/ar500233s","article-title":"A philosophy for CNS radiotracer design","volume":"47","author":"Van de Bittner","year":"2014","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nucmedbio.2024.108905_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203793","article-title":"Euthanasia of laboratory mice: are isoflurane and sevoflurane real alternatives to carbon dioxide?","volume":"13","author":"Marquardt","year":"2018","journal-title":"PloS One"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T20:39:02Z","timestamp":1716669542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":22,"alternative-id":["S0969805124000313"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108905","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin \u2013 A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108905"}}